MedPath

The Effect of GI Biome #7 on Gut Microbiome and Health of the Elderly

Not Applicable
Completed
Conditions
Muscle Weakness
Interventions
Dietary Supplement: GI Biome #7
Dietary Supplement: Placebo
Registration Number
NCT05735418
Lead Sponsor
Seoul National University Hospital
Brief Summary

This study aims to investigate the effects of probiotics named GI Biome #7 on the gut microbiome and muscle strength in older adults aged 60 years or older.

Detailed Description

This study is a double-blind, randomized controlled trial. A total of 60 healthy adults aged 60 years or older will be recruited, and they will be randomly assigned to the intervention group or the control group. The intervention group will be given GI Biome #7 pills, and the control group will be given the placebo pills for four weeks. The participants will visit the research laboratory four times as follows: A day before starting to take the pills, two weeks later after starting to take the pills, the last day of taking the pills, and four weeks later after the end of taking the pills. Participants' stool, blood, and urine will be sampled every visit, and grip strength and body composition will also be checked.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • 60 years old or older
  • Those who have no difficulties in daily living
  • Willing to commit throughout the study
Exclusion Criteria
  • Antibiotics medication in the last month.
  • Probiotics used in the last months.
  • Those who are in the treatment of the following diseases: Liver disease, Neurological disease, Respiratory disease, Tumors, Psychiatric disorders, Angina, Myocardial infarction, and Stroke

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
GI Biome #7GI Biome #7The intervention consists of daily administration of probiotics GI Biome #7 for four weeks.
PlaceboPlaceboThe placebo consists of daily administration of the placebo pills made up of 100% maltodextrin for four weeks.
Primary Outcome Measures
NameTimeMethod
Hand Grip Strength Change4 weeks

Change from baseline hand grip strength at 4 weeks

Secondary Outcome Measures
NameTimeMethod
Fasting blood glucose4 weeks

Change from baseline fasting blood glucose at 4 weeks

Bacteroidetes/Firmicutes Ratio Change4 weeks

Change from baseline Bacteroidetes/Firmicutes ratio in gut microbiome at 4 weeks

Trial Locations

Locations (1)

Seoul National University College of Medicine

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath